Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Amber Yates, MD
Healthcare Provider Associate Director
Pediatric Hematology-Oncology Fellowship Program
Texas Children's Hospital
6701 Fannin Street
Suite 1580
Houston, Texas, United States
Dr. Amber Yates is an Associate Director of the Pediatric Hematology-Oncology Fellowship Program. She is also Co-Director of the Sickle Cell Program, a member of the Hematology Center and Associate Professor Of Pediatrics at Baylor College of Medicine.
Her primary clinical interest is in the care of children with sickle cell disease and other hemoglobin disorders. She is particularly interested in the role of hydroxyurea therapy in improving the lives of children with sickle cell disease, as well as the long term safety and efficacy of hydroxyurea. Her other clinical interests include: hemoglobinopathies and hemolytic anemia.
Dr. Amber Yates is also interested in assisting teenage patients with hematologic disorders so they can achieve a successful transition to adult care.
Representative Publications:
Hydroxyurea treatment of children with hemoglobin SC disease
+myBinderRelated Content
-
Simon Dyson, PhDSimon Dyson is Professor of Applied Soci...
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
-
Aisha Walker, PhDDr. Walker is a Research Assistant Profe...
-
Pediatric Residents’ Perceived Barriers to Opioid Use in Sickle Cell Disease Pain ManagementObjective: Current guidelines recommend...
-
2019 Chicago Sickle Cell SummitThe Chicago Sickle Cell Summit convenes ...
-
Women with Sickle Cell Disease and Postpartum Care: What to Know After Delivering Your BabyPostpartum care is health care you get a...
-
Spearheading change on World Sickle Cell DayThis year on World Sickle Cell Day, a ne...
